News

Inlyta (axitinib) was approved by the FDA for the treatment of advanced renal cell carcinoma (RCC) after failure of one systemic therapy. Inlyta, an oral drug, inhibits certain

The new office will incorporate the company’s commercialization team handling, while retaining its corporate headquarters, with clinical, manufacturing, regulatory and administration functions, remains in Dublin, Ohio, US. Navidea

The product is indicated in the treatment of the reduction of elevated intraocular pressure in patients with open angle glaucoma and ocular hypertension. Latanoprost + Timolol is currently

The collaboration is expected to increase the annual production capability of Sr-82 produced at INR and thereafter increase supply to key markets. Initial shipments of Sr-82 samples are

PhytoMulti, also known as the "Smart Multi" targets cellular health by nourishing cells, recharging cellular communication and defending against free radical damage. PhytoMulti with Iron is a blend

Surgex products contain a proprietary blend of nutrients designed to improve peak power, endurance, and recovery time. The new RTD sports nutrition formula is available in three flavors

AVP-923 combines dextromethorphan hydrobromide and low dose quinidine sulfate, and is currently being investigated in a Phase II clinical trial in central neuropathic pain in patients with multiple

The company will begin the shipment of Meropenem for Injection in 500mg and 1gm single dose vials from 13 February 2012. The Imipenem and Cilastatin for Injection in

The offering includes a new set of cloud-based BI applications that aligns sales and marketing spend with market-driven revenue outcomes linked to comprehensive internal and external market data